Join
Live feed
·
INSIDERFilingvia Quantisnow
Clearside Biomedical Inc. logo

SEC Form 4: Thorp Clay sold $145,627 worth of shares (32,873 units at $4.43) as part of a pre-agreed trading plan, decreasing direct ownership by 0.66% to 4,951,547 units (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.
CLSD· Clearside Biomedical Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLSD (Clearside Biomedical Inc.) and more on Quantisnow.